COMMUNIQUÉS West-GlobeNewswire

Matinas BioPharma Selected to Present at the BioNJ Eighth Annual BioPartnering Conference
01/05/2018
BEDMINSTER, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative medicines using its proprietary lipid [...]
Medtronic Receives FDA Approval for Deep Brain Stimulation Therapy for Medically Refractory Epilepsy
01/05/2018
7-Year Data from the SANTE Trial Showed Median Seizure Frequency Reduction of 75 percent in Patients with Drug-Resistant Epilepsy with Partial-Onset Seizures Receiving DBS Therapy. DUBLIN - May 1, 2018 - Medtronic plc ( [...]
Twinlab Ceo Steps Down
01/05/2018
BOCA RATON, Fla., May 01, 2018 (GLOBE NEWSWIRE) -- Twinlab Consolidated Holdings, Inc. (OTCPK: TLCC) ("TCC" or "Twinlab"), a leading nutritional supplement company, today announced that Chief Executive Officer, Naomi [...]
CareDx Activities at American Transplant Congress
01/05/2018
BRISBANE, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
PolarityTE™ Regenerates Complex, Hierarchically-Organized, Corticocancellous Bone in Preclinical Studies
01/05/2018
SALT LAKE CITY, May 01, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (NASDAQ: COOL ) announced results demonstrating that the Company’s autologous bone product in development, OsteoTE TM , regenerated complex, [...]
Insmed to Present at the Deutsche Bank 43rd Annual Health Care Conference
01/05/2018
BRIDGEWATER, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that Will Lewis, [...]
FeraMAX® Named #1 by Canadian Physicians and Pharmacists for Third Consecutive Year
01/05/2018
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) is pleased to announce that for the third consecutive year, FeraMAX ® has been named the #1 recommended iron supplement brand in a [...]
BioSig Technologies Completes Private Placement
01/05/2018
Capital raised to support operational growth and uplisting to national stock exchange Santa Monica, CA, May 01, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a [...]
Momenta Pharmaceuticals Announces Date of First Quarter 2018 Financial Results Conference Call and Webcast
01/05/2018
CAMBRIDGE, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ), today announced that it will release its financial results for the first quarter ended March 31, 2018 and provide a [...]
Senior Vice President and Chief Clinical Officer Dr. Hoda Asmar Advances Adventist Health Mission With New Patient-Centered Initiatives
01/05/2018
Western U.S. Nonprofit Integrated Health System Moves to Redesign the Delivery of Care and Increase Patient Safety and Engagement ROSEVILLE, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a faith-based, [...]
VBL Therapeutics to Report First Quarter 2018 Financial Results on May 17
01/05/2018
TEL AVIV, Israel, May 01, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Selecta Biosciences to Present at Upcoming Investor Conferences
01/05/2018
WATERTOWN, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]
VBI Vaccines Announces First Quarter 2018 Financial Results and Provides Corporate Update
01/05/2018
-- Enrollment completed in PROTECT Phase 3 clinical study of Sci-B-Vac ® Hepatitis B Vaccine -- -- Key upcoming milestones in 2018 for lead eVLP vaccine candidates, VBI-1501 for prevention of Congenital Cytomegalovirus [...]
Jounce Therapeutics to Present at Deutsche Bank 43rd Annual Health Care Conference
01/05/2018
CAMBRIDGE, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]
CymaBay to Report First Quarter 2018 Financial Results on Tuesday, May 8
01/05/2018
NEWARK, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
Atara Biotherapeutics Expands Commercial Leadership Team with the Appointment of Manuela Maronati as General Manager, Europe
01/05/2018
SOUTH SAN FRANCISCO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Delcath Announces Ratio for Reverse Split Authorization
01/05/2018
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company’s Board of [...]
Release date of three-month interim report (Q1) 2018 and audio cast
01/05/2018
On Friday, 4 May 2018, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) releases its interim report for the three months ended 31 March 2018. ALK will host a meeting for analysts and institutional investors that day at 1.30 [...]
Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients
01/05/2018
Company to Conduct Larger Clinical Study to Evaluate Its Electroceutical™ Therapy in Chronic Kidney Disease LOS ANGELES, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the [...]

Pages